Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2 2Phase 4 1Phase 3 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 9Plasma cell 2Classical hematology 2Breast 2Lymphoid 1Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Lymphoma 35Lymphoma, Follicular 31Lymphoma, Non-Hodgkin 30Leukemia, Lymphocytic, Chronic, B-Cell 16Recurrence 11Lymphoma, Large B-Cell, Diffuse 11Leukemia 11Lymphoma, B-Cell 10Waldenstrom Macroglobulinemia 8Lymphoma, T-Cell, Cutaneous 8Hodgkin Disease 8Mycosis Fungoides 6Lymphoma, Mantle-Cell 6Neoplasm, Residual 5Lymphoma, T-Cell, Peripheral 5Lymphoma, T-Cell 5Lymphoma, Extranodal NK-T-Cell 5Febrile Neutropenia 5Burkitt Lymphoma 5Asthma 5Pain 4Neoplasms 4Multiple Myeloma 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Acute 4Hematologic Diseases 4Sezary Syndrome 3Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3

Interventions

pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Bone Neoplasms × Lymphoid × Clear all
NCT02905916 2016-09-19

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

Peking University

Phase 4 Unknown
217 enrolled
BreastLymphoidSarcoma

Bone Neoplasms, Breast Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡